A research team led by Prof. Maximilian Reichert (left) and Prof. Andreas Bausch has developed a novel organoid model of pancreatic cancer.
Researchers develop innovative organoid model to study pancreatic cancer. A research team led by Prof. Maximilian Reichert ( left ) and Prof. Andreas Bausch has developed a novel organoid model of pancreatic cancer. Researchers at the Technical University of Munich (TUM) have developed a novel model system that can be used to precisely track the growth steps and three-dimensional arrangement of pancreatic cancer cells. It also provides the basis for testing and developing therapeutic approaches. Pancreatic cancer accounts for around 3 percent of all cancer cases in Germany. Although this type of cancer is relatively rare, it is highly aggressive and therefore lethal in most cases. "There is probably no other tumor type where research is so urgently needed," says Maximilian Reichert, professor for translational pancreatic carcinoma research at TUM Klinikum rechts der Isar.
TO READ THIS ARTICLE, CREATE YOUR ACCOUNT
And extend your reading, free of charge and with no commitment.
